Stephanie Halene, MD, PhD, cares for patients with hematologic malignancies, and works to bridge the gap between the clinic and the basic science laboratories.
Featured Stories: Hematology
Humanized Mice Lead to Breakthroughs in Blood Cancers
Humanized mice created at Yale are opening new avenues of research into cancers caused by disorders in the production of blood, such as acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS).
Tasha: Leukemia Survivor
Tasha was diagnosed with acute promyelocytic leukemia, a rare, quick moving subtype of AML where immature white blood cells accumulate in the bone marrow.
Transforming Research for Blood Malignancies
Recent research and medical practice address not only AML but also lesser-known blood malignancies such as MDS and MPNs.New Immunotherapy for Blood Cancers
An innovative new immunotherapy program for patients with certain blood cancers has launched. Chimeric Antigen Receptor (CAR) T-cell therapy reprograms a patient’s own T-cells to target tumor antigens.
A Pathway Towards Better Therapies for T-Cell Lymphoma
Two scientists at Yale are working to change the outcomes for Angioimmunoblastic T-cell lymphoma (AITL), a rare, fast-growing cancer typically diagnosed at an advanced stage.
Collaboration of Care to Battle a Rare Cancer
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare cancer involving the skin, bone marrow, and lymph nodes.
Innovative Care and Brother Love Team Up
When Marc St. Martin was diagnosed with cutaneous T-cell lymphoma (CTCL), he had no way of knowing the impact it would have throughout his family.
Love Knows no Bounds, Not Even Cancer
At the age of 23, Josh Scussell was starting his life, and like most people in their early twenties, cancer was the last thing on his mind.
Denise: Hematologic Cancer Survivor
Denise Iorio was faced with two treatment options when she was diagnosed with myelodysplastic syndrome (MDS), she could take medication to control symptoms, or undergo a stem cell transplant.
Jody: Leukemia Survivor
The team at the Survivorship Clinic helped Jody understand that you are not the same person you were the day before you got diagnosed.
John: Leukemia Survivor
After receiving treatment for melanoma, a bone marrow biopsy confirmed that John had another cancer: acute myeloid leukemia.
Learn more about internationally recognized clinician and clinical researcher Dr. Francine Foss and her expertise in adult lymphomas and in stem cell allotransplantation.
Presentations by: Francine Foss, MD Professor of Medicine (Hematology) and Dermatology, Francesca Montanari, MD Assistant Professor of Clinical Medicine (Hematology), and M. Sung Lee, MD Assistant Professor of Medicine (Medical Oncology)
Early Phase Clinical Trials for Lymphomas
Care of Patients with Myeloma
Hematologic Disorders in Pregnancy